Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 632

1.

Hypofractionated stereotactic radiotherapy for brain metastases--results from three different dose concepts.

Fahrig A, Ganslandt O, Lambrecht U, Grabenbauer G, Kleinert G, Sauer R, Hamm K.

Strahlenther Onkol. 2007 Nov;183(11):625-30.

PMID:
17960338
2.

Phase II trial of hypofractionated stereotactic radiotherapy for brain metastases: results and toxicity.

Ernst-Stecken A, Ganslandt O, Lambrecht U, Sauer R, Grabenbauer G.

Radiother Oncol. 2006 Oct;81(1):18-24.

PMID:
16978720
3.

Hypofractionated stereotactic radiotherapy in combination with whole brain radiotherapy for brain metastases.

Giubilei C, Ingrosso G, D'Andrea M, Benassi M, Santoni R.

J Neurooncol. 2009 Jan;91(2):207-12. doi: 10.1007/s11060-008-9700-8.

PMID:
18807149
4.
5.

[Hypofractionated stereotactic radiotherapy for brain metastases].

Schlienger M, Nataf F, Huguet F, Pene F, Foulquier JN, Orthuon A, Roux FX, Touboul E.

Cancer Radiother. 2010 Apr;14(2):119-27. doi: 10.1016/j.canrad.2009.10.004. Review. French.

PMID:
20004125
6.

Stereotactic radiosurgery and fractionated stereotactic radiotherapy: comparison of efficacy and toxicity in 260 patients with brain metastases.

Fokas E, Henzel M, Surber G, Kleinert G, Hamm K, Engenhart-Cabillic R.

J Neurooncol. 2012 Aug;109(1):91-8. doi: 10.1007/s11060-012-0868-6.

PMID:
22528795
7.

Stereotactic radiotherapy of targets in the lung and liver.

Wulf J, Hädinger U, Oppitz U, Thiele W, Ness-Dourdoumas R, Flentje M.

Strahlenther Onkol. 2001 Dec;177(12):645-55.

PMID:
11789403
8.

Hypofractionated stereotactic radiotherapy for the treatment of brain metastases.

Kwon AK, Dibiase SJ, Wang B, Hughes SL, Milcarek B, Zhu Y.

Cancer. 2009 Feb 15;115(4):890-8. doi: 10.1002/cncr.24082.

9.

Hypofractionated stereotactic radiotherapy as an alternative to radiosurgery for the treatment of patients with brain metastases.

Manning MA, Cardinale RM, Benedict SH, Kavanagh BD, Zwicker RD, Amir C, Broaddus WC.

Int J Radiat Oncol Biol Phys. 2000 Jun 1;47(3):603-8.

PMID:
10837942
10.

Radiosurgery for re-irradiation of brain metastasis: results in 54 patients.

Noël G, Proudhom MA, Valery CA, Cornu P, Boisserie G, Hasboun D, Simon JM, Feuvret L, Duffau H, Tep B, Delattre JY, Marsault C, Philippon J, Fohanno D, Baillet F, Mazeron JJ.

Radiother Oncol. 2001 Jul;60(1):61-7.

PMID:
11410305
11.

Linac stereotactic radiosurgery: an effective and safe treatment for elderly patients with brain metastases.

Noel G, Bollet MA, Noel S, Feuvret L, Boisserie G, Tep B, Delattre JY, Baillet F, Ambroise Valery C, Cornu P, Mazeron JJ.

Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1555-61.

PMID:
16024180
12.

Survival and quality of life after hypofractionated stereotactic radiotherapy for recurrent malignant glioma.

Ernst-Stecken A, Ganslandt O, Lambrecht U, Sauer R, Grabenbauer G.

J Neurooncol. 2007 Feb;81(3):287-94.

PMID:
17031558
13.

[Stereotaxic irradiation of brain metastasis in elderly patients].

Noël G, Noël S, Feuvret L, Valery CA, Cornu P, Boisserie G, Hasboun D, Tep B, Delattre JY, Baillet F, Mazeron JJ.

Bull Cancer. 2003 Oct;90(10):896-904. French.

14.

Hypofractionated stereotactic radiotherapy of limited brain metastases: a single-centre individualized treatment approach.

Märtens B, Janssen S, Werner M, Frühauf J, Christiansen H, Bremer M, Steinmann D.

BMC Cancer. 2012 Oct 25;12:497. doi: 10.1186/1471-2407-12-497.

15.

Hypofractionated conformal stereotactic radiotherapy alone or in combination with whole-brain radiotherapy in patients with cerebral metastases.

Lindvall P, Bergström P, Löfroth PO, Henriksson R, Bergenheim AT.

Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1460-6.

PMID:
15817351
16.

Stereotatic radiosurgery of 468 brain metastases < or =2 cm: implications for SRS dose and whole brain radiation therapy.

Shehata MK, Young B, Reid B, Patchell RA, St Clair W, Sims J, Sanders M, Meigooni A, Mohiuddin M, Regine WF.

Int J Radiat Oncol Biol Phys. 2004 May 1;59(1):87-93.

PMID:
15093903
17.

Analysis of tumor control and toxicity in patients who have survived at least one year after radiosurgery for brain metastases.

Varlotto JM, Flickinger JC, Niranjan A, Bhatnagar AK, Kondziolka D, Lunsford LD.

Int J Radiat Oncol Biol Phys. 2003 Oct 1;57(2):452-64.

PMID:
12957257
18.

Transient enlargement of contrast uptake on MRI after linear accelerator (linac) stereotactic radiosurgery for brain metastases.

Huber PE, Hawighorst H, Fuss M, van Kaick G, Wannenmacher MF, Debus J.

Int J Radiat Oncol Biol Phys. 2001 Apr 1;49(5):1339-49.

PMID:
11286842
19.

Hypofractionated stereotactic radiotherapy alone without whole-brain irradiation for patients with solitary and oligo brain metastasis using noninvasive fixation of the skull.

Aoyama H, Shirato H, Onimaru R, Kagei K, Ikeda J, Ishii N, Sawamura Y, Miyasaka K.

Int J Radiat Oncol Biol Phys. 2003 Jul 1;56(3):793-800.

PMID:
12788187
20.

The impact of whole-brain radiation therapy on the long-term control and morbidity of patients surviving more than one year after gamma knife radiosurgery for brain metastases.

Varlotto JM, Flickinger JC, Niranjan A, Bhatnagar A, Kondziolka D, Lunsford LD.

Int J Radiat Oncol Biol Phys. 2005 Jul 15;62(4):1125-32.

PMID:
15990018

Supplemental Content

Support Center